_version_ 1811282251712823296
author Mathew R. Birnbaum, BS
Michelle W. Ma, MD
Sarah Fleisig, MD
Stuart Packer, MD
Bijal D. Amin, MD
Mark Jacobson, MD
Beth N. McLellan, MD
author_facet Mathew R. Birnbaum, BS
Michelle W. Ma, MD
Sarah Fleisig, MD
Stuart Packer, MD
Bijal D. Amin, MD
Mark Jacobson, MD
Beth N. McLellan, MD
author_sort Mathew R. Birnbaum, BS
collection DOAJ
first_indexed 2024-04-13T01:49:18Z
format Article
id doaj.art-3492f72d68844f56a5e03ddc1f5de302
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-04-13T01:49:18Z
publishDate 2017-05-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-3492f72d68844f56a5e03ddc1f5de3022022-12-22T03:07:56ZengElsevierJAAD Case Reports2352-51262017-05-013320821110.1016/j.jdcr.2017.02.015Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinomaMathew R. Birnbaum, BS0Michelle W. Ma, MD1Sarah Fleisig, MD2Stuart Packer, MD3Bijal D. Amin, MD4Mark Jacobson, MD5Beth N. McLellan, MD6Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New YorkDepartment of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New YorkDepartment of Medicine, Division of Hematology/Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New YorkDepartment of Medicine, Division of Hematology/Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New YorkDepartment of Pathology, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New YorkDepartment of Pathology, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New YorkDepartment of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512617300486immune checkpoint inhibitorsimmune-related adverse eventsimmunotherapynivolumabprogrammed cell death-1sarcoidosis
spellingShingle Mathew R. Birnbaum, BS
Michelle W. Ma, MD
Sarah Fleisig, MD
Stuart Packer, MD
Bijal D. Amin, MD
Mark Jacobson, MD
Beth N. McLellan, MD
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
JAAD Case Reports
immune checkpoint inhibitors
immune-related adverse events
immunotherapy
nivolumab
programmed cell death-1
sarcoidosis
title Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
title_full Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
title_fullStr Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
title_full_unstemmed Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
title_short Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
title_sort nivolumab related cutaneous sarcoidosis in a patient with lung adenocarcinoma
topic immune checkpoint inhibitors
immune-related adverse events
immunotherapy
nivolumab
programmed cell death-1
sarcoidosis
url http://www.sciencedirect.com/science/article/pii/S2352512617300486
work_keys_str_mv AT mathewrbirnbaumbs nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma
AT michellewmamd nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma
AT sarahfleisigmd nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma
AT stuartpackermd nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma
AT bijaldaminmd nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma
AT markjacobsonmd nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma
AT bethnmclellanmd nivolumabrelatedcutaneoussarcoidosisinapatientwithlungadenocarcinoma